In NAFLD, SESN2 helps with postponing disease progression through balancing glycolipid metabolism and macroautophagy (lipophagy), and rectifying oxidative damage and ER stress. This evidence concerns the gene SESN2 and metabolic dysfunction-associated steatotic liver disease.